These findings suggest that GLP-1 receptor agonists may offer a critical advantage in managing diabetes and cardiovascular risk in patients with inflammatory arthritis, said Antonio Avia-Zubieta, Senior Scientist at Arthritis Research Canada and Principal Investigator in this study
Psychol Med (2007) 37(1):13141
As mismo, la administracin intraperitoneal de liraglutida antes del procedimiento de oclusin de la arteria coronaria en ratones disminuye el tamao del rea infartada, probablemente mediante la inhibicin de la activacin de la caspasa-3 en cardiomiocitos.42
I don't think it's too much to ask of us that we educate ourselves on GLP-1 agonists and prescribe them thoughtfully
Retatrutides safety profile demonstrated tolerable side effects, predominantly gastrointestinal disturbances, underscoring the need for patient guidance and monitoring
(9) Ernest Adeghate and Abdul Samad Ponery (2004) Mechanism of ipamorelin-evoked insulin release from the pancreas of normal and diabetic rats Neuro Endocrinology Letters, 2004 Dec, Volume 25 (Issue 6), Pages 403-6